Get the Stockscreener App
494.14
2.83%
14.09
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $494.14, with a volume of 1.31M.
It is up +2.83% in the last 24 hours and down -5.28% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$480.05
Open:
$487.75
24h Volume:
1.31M
Relative Volume:
0.58
Market Cap:
$183.48B
Revenue:
$44.56B
Net Income/Loss:
$6.72B
P/E Ratio:
27.86
EPS:
17.7387
Net Cash Flow:
$6.29B
1W Performance:
+0.68%
1M Performance:
-5.28%
6M Performance:
+1.77%
1Y Performance:
-0.80%
1-Day Range:
$479.65
$493.93
1-Week Range:
$471.83
$499.95
52-Week Range:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
493.91 | 178.33B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
189.68 | 130.14B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
563.72 | 44.25B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.29 | 31.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
297.92 | 28.78B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | DZ Bank | Buy |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM - The Joplin Globe
Northstar Advisory Group LLC Acquires Shares of 5,609 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by James Hambro & Partners LLP - MarketBeat
J. Safra Sarasin Holding AG Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mn Services Vermogensbeheer B.V. Has $84.72 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
How is Thermo Fisher (TMO) Preparing to Deal With Rising Helium Prices - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Thermo Fisher Scientific (TMO) Sets Stage for Q4 Rally with Impressive Q3 Earnings and New 52-Week High - Yahoo Finance
U.S. Automated Analyzer Market Is Going to Boom| Thermo Fisher - openPR.com
Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey
Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.
Food Testing Kits Market Is Going to Boom | Thermo Fisher Scientific • Eurofins Scientific • SGS SA - openpr.com
Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National Today
Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by DAVENPORT & Co LLC - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know - TradingKey
Vanguard Amends 13G: Reports 0 Shares in Thermo Fisher (TMO) - Stock Titan
Thermo Fisher Scientific collaborates with SHL Medical and expands Ridgefield site - ROI-NJ
Thermo Fisher Scientific (NYSE:TMO) Earns Buy Rating from Analysts at DZ Bank - MarketBeat
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release - Barchart
Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now? - Yahoo Finance
U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com
Czech National Bank Purchases 3,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
CCM Investment Advisers LLC Sells 2,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Sci. stock faces pressure amid life sciences slowdown and acquisition scrutiny as of M - AD HOC NEWS
Thermo Fisher, SHL Medical collab on drug delivery device production - Drug Delivery Business
Thermo Fisher and SHL Medical partner on integrated drug device solutions - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - BioSpace
Thermo Fisher completes $8.9B buyout of Clario - MedTech Dive
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Registry - Contract Pharma
Thermo Fisher Scientific and SHL Medical collaborate to deliver fully integrated Drug-Device Solutions - marketscreener.com
Thermo Fisher Scientific acquires Clario for nearly $8.9bn - Clinical Trials Arena
Thermo Fisher Scientific completes Clario Holdings acquisition - Medical Buyer
Thermo Fisher Scientific Inc. $TMO Stake Decreased by Professional Advisory Services Inc. - MarketBeat
U.S. Compound Management Market Is Going to Boom | Thermo Fisher - openPR.com
Thermo Fisher Scientific: Early Clario Close Enhances 2026 Growth Outlook and AI-Driven Competitive Position, Supporting Buy Rating - TipRanks
List of 55 Acquisitions by Thermo Fisher Scientific (Mar 2026) - Tracxn
Daymark Wealth Partners LLC Buys 7,003 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
PE investor group completes sale of clinical trial data firm Clario to Thermo Fisher for $8.9bn - pehub.com
Thermo Fisher Completes Strategic Acquisition of Clario Holdings - TipRanks
Thermo Fisher Scientific Inc. (TMO) announces the opening of cryo-electron microscopy drug discovery center in South San Francisco - MSN
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.15% on Mar 24: Facts Behind the Movement - TradingKey
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.04%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):